TREOSUL is now Swissmedic approved and available!!!
A Swiss Pharmaceutical Specialty-Care Group
40+ Years of expertise in Oncology, Orphan & Rare Diseases, Hepatology, Hematology and Infectious Diseases
TREOSUL is now Swissmedic approved and available!!!
40+ Years of expertise in Oncology, Orphan & Rare Diseases, Hepatology, Hematology and Infectious Diseases
IDEOGEN is a Swiss pharmaceutical company with a focus on providing patients, payers and caregivers a solution for accessing specialty care therapies in the fields of haematology, oncology, nephrology, cardiology, infectious diseases and rare/orphan diseases.
We provide a comprehensive range of services in the field of Speciality Care and support international pharmaceutical companies for their early access programs in Europe, Middle East & North African countries.
As a partner to global pharmaceutical R&D companies, we provide them a spring board in accessing the Swiss pharmaceutical market with our experienced team and extensive industry know-how.
Our medical advisory team support doctors and pharmacists permanently with the ultimate goal of their patients’ wellbeing. The executive team has global pharma experience in Speciality Care for more than 40 years. The medical marketing and key account specialists have full hospital coverage. The regulatory, quality and drug safety team consist of in house specialists and external consultants.
SWITZERLAND
As patients’ wellbeing is the priority for Ideogen, we provide doctors and pharmacists orphan drugs on a regular Swissmedic registered basis or through early access programs. Our clear focus is on original molecules within the therapeutical fields of haematology, oncology and infectious diseases.
With our network and market know-how, we identify pharmaceutical products, which have been deregistered from the Swiss market for commercial reasons and reregister them for having a constant supply of these within the Swiss market. We partner up with other pharmaceutical companies to continue to carry their products if they themselves do not want to be active in the Swiss market or if the products do not fit to their portfolio anymore.
GLOBAL
Our extensive market knowhow about speciality care in more than 110 countries enables us to run early as well as regular access programs for the products of our global partners. With our offices in the European and MENA countries, we provide on the spot support for healthcare professionals
Heute geöffnet | 09:00 – 17:00 |
Copyright © 2018 Ideogen – Alle Rechte vorbehalten.
COPYRIGHT
All the information on our website has been carefully checked and its contents are continually being added to and updated. Nonetheless, although we carefully check the content, we cannot guarantee that it is complete, correct or fully up to date.
COPYRIGHT & TRADEMARKS
The royalty-free use, copying or distribution of this documentation is hereby granted only for non-commercial purposes, provided the copyright notice set out here appears in all copies and both the copyright and this notice of permission appear in supporting documents. Use of the name Ideogen in advertising in connection with the distribution of this documentation requires the specific written permission of Idoegen. All information, documents, and images on this page are the property of the Ideogen and may only be used on this page. Use without prior consent is prohibited.
HEALTH INFORMATION
This website may contain medical and health-related information. This information cannot, however, be considered to be substitute for the advice of a doctor, pharmacist or other health professional, and should not be used for self-diagnosis or the diagnosis of other persons. Scientific data and information regarding development of products or therapies correspond to the situation when they were first published and are therefore subject to change of any kind.
DISCLAIMER
We make every effort to provide you with accurate and up-to-date information. However, Ideogen accepts no responsibility for damage associated with this information or changes to it. For this reason we give neither expressly nor implicitly any warranty or guarantee and provide no assurance in respect of the correctness or completeness of the information provided or referred to. Any use of our website or of any other pages linked to it by means of hyperlinks or their content is at the user's own risk.
Neither Ideogen nor its subsidiaries, nor any other party concerned with the manufacture, provision, design or maintenance of the entire internet offering or individual parts thereof is in any way liable for any immediate or consequential damage, culpable damage or damage regardless of culpability which might arise from access to the internet offering, its use or in particular the inability to use the internet offering of Ideogen or the information provided in connection with it. Ideogen is not responsible for the availability of the websites of third parties or their content. Any use of hyperlinks to these websites is at the user's own risk and implies no liability on the part of Ideogen.
Before the use or application of our products, note should be taken of the related instructions for use. Rights may only be inferred from the instructions included with the products, and not from use of the product information on this website.
The Morbus Wilson Treatment is now SWISSMEDIC APPPROVED, on the SL list and availabe for your patients!